ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
雍和植发(临时代码)
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
数据加载中...
总览
公司
新闻
公告
康方生物-B:派安普利单抗(PD-1)三线治疗转移性鼻咽癌获FDA授予突破性疗法认定
智通财经
·
2021-03-30
【异动股】康方生物-B(09926-HK)涨10.08%
金融界网站
·
2021-03-26
康方生物-B(09926-HK)跌3.83%
财华社
·
2021-03-24
【异动股】康方生物-B(09926-HK)跌4.41%
金融界网站
·
2021-03-23
康方生物-B(09926.HK)3月31日举行董事会会议审批年度业绩
格隆汇
·
2021-03-19
09926--康方生物-B:董事會會議召開日期
同花顺
·
2021-03-19
康方生物-B(09926)坚守创新,行稳致远的肿瘤免疫新势力
国泰君安
·
2021-03-18
国泰君安:给予康方生物-B(09926.HK)“买入”评级 目标价56.81港元
同花顺金融研究...
·
2021-03-17
康方生物-B(09926-HK)涨3.41%
财华社
·
2021-03-15
康方药业一期在广州黄埔投产
信息时报
·
2021-03-12
【异动股】康方生物-B(09926-HK)涨7.06%
金融界网站
·
2021-03-11
格隆汇港股通5日资金流入流出排行榜 | 3月10日
金融界网站
·
2021-03-11
康方生物-B(09926-HK)跌8.03%
财华社
·
2021-03-08
康方生物-B盘中异动 急速跳水5.17%报44.901港元
自选股智能写手
·
2021-03-08
生物医药股集体大跌 康方生物跌近10%康希诺生物跌近9%
新浪港股
·
2021-03-04
大和降康方生物(09926-HK)目标价至58.6港元 股价现跌7.34%
财华社
·
2021-03-03
料缺乏短期催化剂 大和降康方生物(09926)至“跑赢大市”评级
金吾财经
·
2021-03-03
康方生物-B(09926-HK)跌3.27%
财华社
·
2021-03-02
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90010/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90010","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","market":"HK","secType":"STK","nameCN":"雍和植发(临时代码)","latestPrice":0,"timestamp":1747296000000,"preClose":0,"halted":8,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":0,"latestTime":"05-15 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":0,"symbolChange":{"newSymbol":"09926","executeDate":"2020-04-14"},"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90010\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2123268595","title":"康方生物-B:派安普利单抗(PD-1)三线治疗转移性鼻咽癌获FDA授予突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2123268595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2123268595?lang=zh_cn&edition=fundamental","pubTime":"2021-03-30 06:29","pubTimestamp":1617056955,"startTime":"0","endTime":"0","summary":"康方生物-B(09926)发布公告,该公司与中国生物制药有限公司(01177)共同开发的PD-1单抗药物派安普利单抗(安尼可)(研发代号:AK105)三线治疗转移性鼻咽癌,获得美国食品药品监督管理局(FDA)授 ...","market":"sh","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20210330/c628173378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["90010","09926"],"gpt_icon":0},{"id":"2122142744","title":"【异动股】康方生物-B(09926-HK)涨10.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2122142744","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2122142744?lang=zh_cn&edition=fundamental","pubTime":"2021-03-26 13:22","pubTimestamp":1616736153,"startTime":"0","endTime":"0","summary":"【财华社讯】康方生物-B(09926-HK)截至13:22上涨10.08%,现报48.6港元,涨4.45港元。成交219万股,涉资1.025亿元。(出处:FinetAI)","market":"us","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/26132232222206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90010","09926"],"gpt_icon":0},{"id":"2121456948","title":"康方生物-B(09926-HK)跌3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2121456948","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2121456948?lang=zh_cn&edition=fundamental","pubTime":"2021-03-24 14:33","pubTimestamp":1616567580,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至14:30下跌3.83%,现报42.7港元,跌1.7港元。成交232万股,涉资1.003亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202103241856951584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90010","09926"],"gpt_icon":0},{"id":"2121483864","title":"【异动股】康方生物-B(09926-HK)跌4.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2121483864","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2121483864?lang=zh_cn&edition=fundamental","pubTime":"2021-03-23 14:49","pubTimestamp":1616482154,"startTime":"0","endTime":"0","summary":"【财华社讯】康方生物-B(09926-HK)截至14:49下跌4.41%,现报44.45港元,跌2.05港元。成交226万股,涉资1.019亿元。(出处:FinetAI)","market":"hk","thumbnail":"https://static.tigerbbs.com/c318bcd91a109139b7d70c76c30bb154","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c318bcd91a109139b7d70c76c30bb154"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/23144932201365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09926","90010"],"gpt_icon":0},{"id":"2120164739","title":"康方生物-B(09926.HK)3月31日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2120164739","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2120164739?lang=zh_cn&edition=fundamental","pubTime":"2021-03-19 06:37","pubTimestamp":1616107067,"startTime":"0","endTime":"0","summary":"格隆汇 3 月 19日丨康方生物-B(09926.HK)发布公告,公司将于2021年3月31日(星期三)举行董事会会议,藉以(其中包括)考虑及批准公司及其附属公司于截至2020年12月31日止年度的年度业绩及其发布。","market":"hk","thumbnail":"https://static.tigerbbs.com/cb94707725a5c97e34b5305626765aec","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb94707725a5c97e34b5305626765aec"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/news/detail.html?id=498605","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["90010","09926"],"gpt_icon":0},{"id":"2120934341","title":"09926--康方生物-B:董事會會議召開日期","url":"https://stock-news.laohu8.com/highlight/detail?id=2120934341","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2120934341?lang=zh_cn&edition=fundamental","pubTime":"2021-03-19 06:09","pubTimestamp":1616105386,"startTime":"0","endTime":"0","summary":"原标题:09926--康方生物-B:董事會會議召開日期 来源:联交所--披露易香港交易及結算所有限 公司及香港聯合交易所 有限公司對本公告之內 容概不負責,對其準確性或完整性亦不發 表任何聲明,並明 確表示,概不就因本 公告全部或任何 部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何 責任。A ke so , In c .康 方 生 物 科 技(開 曼 )有 限 公 司(於 開 曼 群 島","market":"hk","thumbnail":"https://static.tigerbbs.com/8844d34a68c737501939fc425fd6195b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8844d34a68c737501939fc425fd6195b"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-19/doc-ikkntiam5311688.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-19/doc-ikkntiam5311688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09926","90010"],"gpt_icon":0},{"id":"2120150521","title":"康方生物-B(09926)坚守创新,行稳致远的肿瘤免疫新势力","url":"https://stock-news.laohu8.com/highlight/detail?id=2120150521","media":"国泰君安","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2120150521?lang=zh_cn&edition=fundamental","pubTime":"2021-03-18 09:20","pubTimestamp":1616030419,"startTime":"0","endTime":"0","summary":"康方生物-B坚守创新,行稳致远的肿瘤免疫新势力 来源:国泰君安本报告导读:康方生物坚守自主创新,ACE平台和TETRABODY自有技术价值凸显,创新研发能力得到不断论证,在研管线丰富且进入兑现期。早在2015年,公司就将自主研发的CTLA-4单抗以总对价2亿美金授权给Merck,成为中国首个向全球制药龙头对外授权的biotech。2021年将是公司商业化元年,有望凭借PD-1单抗的上市,不断打开在肿瘤免疫领域的布局。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-18/doc-ikkntiam4580303.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-18/doc-ikkntiam4580303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90010","09926"],"gpt_icon":0},{"id":"2120613540","title":"国泰君安:给予康方生物-B(09926.HK)“买入”评级 目标价56.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2120613540","media":"同花顺金融研究...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2120613540?lang=zh_cn&edition=fundamental","pubTime":"2021-03-17 17:32","pubTimestamp":1615973522,"startTime":"0","endTime":"0","summary":"原标题:国泰君安:给予康方生物-B(09926.HK)“买入”评级 目标价56.81港元 来源:同花顺金融研究中心 国泰君安3月17日发布公告。首次覆盖,给予“增持”评级。康方生物坚守自主创新,在研管线丰富,且管线品种具备内部combo的研发优势,2021年产品陆续进入商业化兑现期。我们预测2020-2022年收入分别为0.34/5.62/18.98亿元人民币,由于公司尚未有商业化产品,我们采用DCF绝对估值法和相对估值法,给予目标价56.81港元,首次覆盖,给予增持评级。","market":"sh","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-17/doc-ikknscsi7147966.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-17/doc-ikknscsi7147966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90010","02611","09926","601211"],"gpt_icon":0},{"id":"2119918848","title":"康方生物-B(09926-HK)涨3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2119918848","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2119918848?lang=zh_cn&edition=fundamental","pubTime":"2021-03-15 13:21","pubTimestamp":1615785660,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至13:19上涨3.41%,现报45.5港元,涨1.5港元。成交221万股,涉资1.002亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202103151843895058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09926","90010"],"gpt_icon":0},{"id":"2118349479","title":"康方药业一期在广州黄埔投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2118349479","media":"信息时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118349479?lang=zh_cn&edition=fundamental","pubTime":"2021-03-12 07:54","pubTimestamp":1615506863,"startTime":"0","endTime":"0","summary":"信息时报讯(记者 张玉琴 通讯员 孙旭东)3月10日,康方生物位于中新广州知识城的生物制药生产基地康方药业项目一期正式投产。这是继百济神州后,今年黄埔区、广州开发区又一生物制药头部企 ...","market":"sh","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20210312/c627712976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["09926","90010"],"gpt_icon":0},{"id":"2118600575","title":"【异动股】康方生物-B(09926-HK)涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2118600575","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118600575?lang=zh_cn&edition=fundamental","pubTime":"2021-03-11 11:20","pubTimestamp":1615432830,"startTime":"0","endTime":"0","summary":"【财华社讯】康方生物-B(09926-HK)截至11:20上涨7.06%,现报44港元,涨2.9港元。成交244万股,涉资1.074亿元。(出处:FinetAI)","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/11112032108318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09926","90010"],"gpt_icon":0},{"id":"2118160827","title":"格隆汇港股通5日资金流入流出排行榜 | 3月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2118160827","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118160827?lang=zh_cn&edition=fundamental","pubTime":"2021-03-11 05:10","pubTimestamp":1615410601,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,康方生物-B,首控集团,山东墨龙,呷哺呷哺,启明医疗-B港股通五日资金显著流入,五日持仓占比变动分别为,0.49%,0.42%,0.37%,0.36%,0.25%。 港股通数据为T+2数据,即今日披露数据为前两个交易日数据。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/11051032106519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09926","02500","90010","00493"],"gpt_icon":0},{"id":"2117266331","title":"康方生物-B(09926-HK)跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2117266331","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117266331?lang=zh_cn&edition=fundamental","pubTime":"2021-03-08 11:41","pubTimestamp":1615174860,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至11:36下跌8.03%,现报43.55港元,跌3.8港元。成交224万股,涉资1.019亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202103081834209865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90010","09926"],"gpt_icon":0},{"id":"2117664016","title":"康方生物-B盘中异动 急速跳水5.17%报44.901港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2117664016","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117664016?lang=zh_cn&edition=fundamental","pubTime":"2021-03-08 09:50","pubTimestamp":1615168253,"startTime":"0","endTime":"0","summary":"2021年03月08日早盘09时50分,康方生物-B股票出现异动,股价急速跳水5.17%。截至发稿,该股报44.901港元/股,成交量26.3万股,换手率0.03%,振幅6.55%。资金方面,该股资金流入335.715万港元,流出667.845万港元。康方生物-B股票所在的生物技术行业中,整体涨幅为4.45%。其相关个股中,再鼎医药-SB、百济神州、基石药业-B涨幅较大,振幅较大的相关个股有奥星生命科技、永泰生物-B、康方生物-B,振幅分别为8.59%、4.73%、4.22%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103080950537a4a97d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103080950537a4a97d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90010","09926"],"gpt_icon":0},{"id":"2116527934","title":"生物医药股集体大跌 康方生物跌近10%康希诺生物跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116527934","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116527934?lang=zh_cn&edition=fundamental","pubTime":"2021-03-04 11:47","pubTimestamp":1614829620,"startTime":"0","endTime":"0","summary":"3月4日消息,生物医药股集体大跌,康方生物跌近10%,荣昌生物、康希诺生物跌近9%,云顶新耀跌8%,药明巨诺跌超7%,诺诚健华跌超6%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:马婕","market":"us","thumbnail":"https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2021-03-04/doc-ikftpnnz1892479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09926","90010","161726","688185","399441"],"gpt_icon":0},{"id":"2116514704","title":"大和降康方生物(09926-HK)目标价至58.6港元 股价现跌7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116514704","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116514704?lang=zh_cn&edition=fundamental","pubTime":"2021-03-03 10:39","pubTimestamp":1614739140,"startTime":"0","endTime":"0","summary":"大和降康方生物(09926-HK)目标价至58.6港元及评级。康方生物近日公布,公司与中国生物制药(01177-HK)共同开发的抗PD-1单抗药物派安普利(安尼可)(研发代号:AK105)联合紫杉醇和...","market":"hk","thumbnail":"https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202103031828445419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90010","09926"],"gpt_icon":0},{"id":"2116384511","title":"料缺乏短期催化剂 大和降康方生物(09926)至“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2116384511","media":"金吾财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116384511?lang=zh_cn&edition=fundamental","pubTime":"2021-03-03 09:11","pubTimestamp":1614733887,"startTime":"0","endTime":"0","summary":"凤凰网港股|大和发研报指,康方生物于2月24日宣布,AK105(抗PD-1抗体)联合化疗一线治疗鳞状非小细胞肺癌的III期临床试验中期分析已达到主要终点。故此,大和认为该公司缺乏短期催化剂。另外,该行也注意到最近投资者情绪的变化,开始从追逐生物技术部门的增长,到选择具有高质量收益的迟缓者,因为其变得更加具有防御性。大和将康方生物(09926)评级由“买入”降至“跑赢大市”,指该股不再为其生物技术行业的首选,主要由于短期催化剂很少,而生物技术行业的投资者信心相对较弱。同时,该行还将其目标价由70港元下调至58.6港元。","market":"us","thumbnail":"https://d.ifengimg.com/w100_h62_q90/x0.ifengimg.com/ucms/2021_10/DABB8BEE5A02467B19839618BE4ADD316CD9D4AE_size10_w257_h162.jpg","type":0,"news_type":0,"thumbnails":["https://d.ifengimg.com/w100_h62_q90/x0.ifengimg.com/ucms/2021_10/DABB8BEE5A02467B19839618BE4ADD316CD9D4AE_size10_w257_h162.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/84IsL4JWTGB","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["09926","90010"],"gpt_icon":0},{"id":"2116564830","title":"康方生物-B(09926-HK)跌3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116564830","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116564830?lang=zh_cn&edition=fundamental","pubTime":"2021-03-02 14:16","pubTimestamp":1614665760,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至14:15下跌3.27%,现报53.2港元,跌1.8港元。成交185万股,涉资1.001亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202103021826973631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09926","90010"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90010\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2020-04-14","symbol":"90010","oldSymbol":"90010","newSymbol":"09926","exchange":"SEHK","type":"symbolChange","dateTimestamp":1586793600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90010\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90010\",market:\"HK\",delay:false,,,undefined,":{}}}